Last reviewed · How we verify
NCT07473063
Optimization of Heart Failure Treatment and Implementation of a Risk-based Patient Care Model.
trial in Heart Failure in 2,428 participants. Completed in 30 June 2024.
30 June 2023
Quick facts
| Lead sponsor | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,428 |
| Start date | 1 January 2017 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Italy |
Conditions studied
- Heart Failure — all drugs for Heart Failure →
Sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS — full company profile →
Who can join
Adults 18 to 100, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Collection of data from patients with heart failure, both in the acute phase (data collection during hospital admission) and in the chronic phase (data collection during outpatient follow-up), optimization of the treatment of patients with heart failure, and implementation of a care model based on risk stratification.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07473063
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS trials
Trials by the same sponsor.
- NCT07203768 — A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes · recruiting
- NCT07317011 — "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico. · recruiting
- NCT07442760 — ePro Diary - HDV ( MACROLIVER ) · recruiting
- NCT06626685 — Clonal Hematopoiesis of Indeterminate Potential in Heart Failure. · recruiting
- NCT06752941 — LOW-PV Continuation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07473063 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- Last refreshed: 16 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07473063.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing